Stay updated on Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history, and earlier notices such as the funding lapse message and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide funding-status notice and Revision: v3.4.1; removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe new version adds a glossary toggle, introduces color-coded highlights for additions and deletions, and updates the revision information.SummaryDifference0.5%

- Check42 days agoChange DetectedOn 2026-01-09, the record history shows updates to Contacts/Locations and Study Status. The update is associated with Revision: v3.3.4, with a prior Revision: v3.3.3 removed on 2025-09-30.SummaryDifference0.3%

- Check64 days agoChange DetectedA new 'Revision: v3.3.3' tag appears; the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' label were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRecord History shows an added Revision: v3.3.2 and removed Revision: v3.2.0, with no substantive changes to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.